Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19

被引：13
|
作者：
Mendez, Sean R. [1 ]
Frank, Rachel C. [2 ]
Stevenson, Elizabeth K. [5 ]
Chung, Mabel [3 ,4 ,6 ]
Silverman, Michael G. [2 ,4 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Crit Care & Pain Med, Dept Anesthesia, Boston, MA USA
[4] Massachusetts Gen Hosp, Heart Ctr Intens Care Unit, Boston, MA USA
[5] North Shore Med Ctr, Crit Care, Div Pulm, Salem, MA USA
[6] Smith Ctr Outcomes Res Cardiol, Div Cardiovascular Med, Dept Med, Beth Israel Deaconess Med Center, Boston, MA USA
来源：
CHEST | 2021年 / 160卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.chest.2021.01.073
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：89 / 93
页数：5
相关论文
共 50 条
  • [1] Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
    Esteban-Lucia, L.
    Chacon, M. A. Zambrano
    Rodriguez, A. M. Venegas
    Devesa-Arbiol, A.
    Gonzalez-Rodriguez, M.
    Maure-Blesa, L.
    Avila-Barahona, P.
    Pello-Lazaro, A. M.
    Gonzalez-Lorenzo, O.
    Kallmeyer-Mayor, A. M.
    Fernandez-Roblas, R.
    Villar-Alvarez, F.
    Tunon, J.
    Navarro, A. Acena
    Franco-Pelaez, J. A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3006 - 3006
  • [2] Dihydropyridine calcium channel blockers and renal disease
    Robles, Nicolas R.
    Fici, Francesco
    Grassi, Guido
    HYPERTENSION RESEARCH, 2017, 40 (01) : 21 - 28
  • [3] NEW DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    KOROLKOVAS, A
    DEARAUJO, MB
    LIMA, F
    REVISTA BRASILEIRA DE MEDICINA, 1991, 48 (09) : 597 - &
  • [4] Dihydropyridine Calcium Channel Blockers and Kidney Outcomes
    Blum, Matthew F.
    Surapaneni, Aditya
    Chang, Alexander
    Inker, Lesley A.
    Chen, Teresa K.
    Appel, Lawrence J.
    Shin, Jung-Im
    Grams, Morgan E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (10) : 1880 - 1886
  • [5] Dihydropyridine calcium channel blockers and renal disease
    Nicolás R Robles
    Francesco Fici
    Guido Grassi
    Hypertension Research, 2017, 40 : 21 - 28
  • [6] Dihydropyridine Calcium Channel Blockers and Incident Albuminuria
    Blum, Matthew F.
    Surapaneni, Aditya L.
    Chang, Alex R.
    Inker, Lesley A.
    Shin, Jung-Im
    Grams, Morgan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 528 - 528
  • [7] Perioperative use of dihydropyridine calcium channel blockers
    Poelaert, J
    Roosens, C
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2000, 44 (05) : 528 - 535
  • [8] Dihydropyridine Calcium Channel Blockers and the Progression of Parkinsonism
    Marras, Connie
    Gruneir, Andrea
    Rochon, Paula
    Wang, Xuesong
    Anderson, Geoff
    Brotchie, Jonathan
    Bell, Chaim M.
    Fox, Susan
    Austin, Peter C.
    ANNALS OF NEUROLOGY, 2012, 71 (03) : 362 - 369
  • [9] Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers
    Choksi, Tatvam T.
    Zhang, Hui
    Chen, Thomas
    Malhotra, Nikhil
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (03) : 250 - 260
  • [10] Use of Calcium Channel Blockers and the Risk of All-cause Mortality and Severe Illness in Patients With COVID-19: A Systematic Review and Meta-analysis
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 199 - 205
12345